Results 81 to 90 of about 919 (164)
A Review of Current Management of Vitreomacular Traction and Macular Hole
Journal of Ophthalmology, 2015 The paper presents a review of the sequence of events of posterior vitreous detachment (PVD), vitreomacular adhesion (VMA), vitreomacular traction (VMT), and macular hole (MH) from their pathophysiological aspects, clinical features, diagnostic ...
Alfredo García-Layana +5 more
doaj +1 more source
Pneumatic vitreolysis for management of symptomatic focal vitreomacular traction
Journal of Ophthalmic & Vision Research, 2017 Pneumatic vitreolysis (PVL) is the intravitreal injection of a small quantity of expansile gas for the purpose of achieving focal vitreomacular traction (VMT) release for eyes with symptomatic VMT, or inducing VMT release and closure of the macular ...
Clement K Chan +2 more
doaj +1 more source
, 2022 Symptomatic vitreomacular adhesion (sVMA) impedes visual acuity and quality. Ocriplasmin is a recombinant protease, which may be injected into the vitreous cavity to treat this condition, yet controversy remains with respect to its effectiveness and ...
Min Li (12799) +4 more
core +1 more source
Ocriplasmin in the treatment of vitreomacular traction – for
Acta Ophthalmologica, 2017 SummaryEnzymatic vitreolysis for the treatment of vitreomacular traction (VMT) and small macular holes with traction instead of pars plana vitrectomy is a hot debate currently.Ocriplasmin may give a fast and easy solution to the VMT and small macular holes with traction with minimal patient's discomfort and only trasient side effects.Pars plana ...
Xirou, T., Chatziralli, I.
openaire +2 more sources
Clinical Ophthalmology, 2016 Edward William James Pritchard,1 Shams-Ulislam Ilyas,1 Soha Khaled Amar,2 Yit Chuin Yang,3 Nirodhini Narendran1 1Ophthalmology Department, Wolverhampton Eye Infirmary, New Cross Hospital, Royal Wolverhampton Hospitals NHS Trust, Wolverhampton, 2College ...
Pritchard EWJ +4 more
doaj
, 2016 Background: To evaluate the functional recovery of patients with symptomatic vitreomacular traction (VMT) after Ocriplasmin treatment. Methods: Prospective, single centre, consecutive case series.
ROSSI, Settimio +5 more
core +1 more source
Visual function response to ocriplasmin for the treatment of vitreomacular traction and macular hole [PDF]
, 2017 Purpose: To assess the effect of an intravitreal ocriplasmin injection on visual function, measured using visual acuity (VA) and vision-related quality of life.
Lescrauwaet, Benedicte +8 more
core +1 more source
, 2019 PURPOSE: To evaluate the anatomical and functional outcomes with ocriplasmin in patients with vitreomacular traction (VMT) with or without macular hole (MH).
Spera, Claudio +11 more
core +1 more source
, 2015 Purpose The evaluation of the safety and preliminary efficacy of 125 μg ocriplasmin intravitreal injection in patients with focal vitreomacular adhesion (VMA) and exudative age-related macular degeneration (AMD).
R. L. Novack +4 more
core +1 more source
Acute vision loss after ocriplasmin use
, 2015 Copyright © by Ophthalmic Communications Society, Inc. Purpose: There have been reports in the literature of transient vision loss after ocriplasmin injection and ellipsoid layer disruption on spectral domain optical coherence tomography.
Reiss, Benjamin +3 more
core +1 more source